Chemical Genomics Paradigm for Epigentic Regulation
Chemical Genomics Paradigm for Epigentic Regulation
批准号:
8608445
负责人:
Ming-Ming Zhou
金额:
$92.74万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-24 至 2016-01-31
关键词:
AffinityBindingBioinformaticsBiologicalBiologyBiomedical ResearchBromodomainCell Fate ControlCellsChemicalsChromatinChromatin StructureCommunitiesDNADNA Modification ProcessDevelopmentDiseaseEmbryoEpigenetic ProcessEquilibriumExcisionGene ExpressionGenesGenetic TranscriptionGenomicsGoalsHealthHeartHistonesHumanHuman BiologyHuman GenomeInformaticsInterdisciplinary StudyInvestigationKnowledgeLigandsLinkLysineMethodologyMethodsModificationMolecularOutcomePHD FingerPathway interactionsPhasePhysiologicalProductionProteinsPublicationsRNA InterferenceReaderRegulationReportingResearchResearch PersonnelResearch Project GrantsSomatic CellStem cellsStimulusStructureTechnologyTertiary Protein StructureTestingTranscriptional RegulationValidationbasec-myc Genescell behaviorcell transformationcell typecomplex biological systemsdesignempoweredepigenomeepigenomicsinduced pluripotent stem cellinhibitor/antagonistinsightknockout geneknowledge basemultidisciplinaryprogramsresponseself-renewalsmall moleculesmall molecule librariesstemstem cell biologythree dimensional structuretooltranscription factor
中文摘要
描述(申请人提供):人类基因组对生理和环境刺激的基因表达是由DNA和DNA包装组蛋白以及转录因子的化学修饰决定的。这个高度复杂的生物系统与大量不同的表观遗传修饰组合一起运作,这违背了我们用现有工具对其基本机制进行的全面调查。干细胞生物学就是一个最好的例子,在干细胞生物学中,自我更新和分化之间的平衡是其染色质结构如何制定不同的转录程序来指导多能细胞行为的核心。Yamanaka使用四个转录因子Oct3/4、Sox2、Klf4和c-Myc(OSKM)将体细胞重新编程为诱导的多能干细胞,突显了通过基因转录最终控制细胞命运。然而,OSKM因子如何改变细胞的表观基因组,以及它们自身在干细胞自我更新和分化过程中的表达如何受到控制的问题还没有得到回答。表观遗传修饰的功能效应是通过与表观基因组阅读器的结合来实现的,如转录和染色质调节基因中存在的乙酰赖氨酸结合溴域和甲基赖氨酸结合染色域。与RNA干扰或基因敲除需要移除整个蛋白质及其所有相互作用不同,小分子抑制物(化学探针)可以消除内源形式的多域蛋白质中的单一相互作用,从而为复杂生物系统的时间扰动提供了更好的工具。在这个多学科的研究项目中,我们将为一组在干细胞生物学中发挥作用的溴结构域和染色质结构域开发高亲和力和选择性的化学探针,无论是单独的(即单靶标探针)还是作为生物途径中的一组(即多靶标探针)。我们的研究使用了一套连贯的结构/化学生物学和染色质/干细胞生物学方法,这些方法是由我们的关键研究人员开发的,具有多学科的专业知识。我们还将开发一个表观基因组阅读器知识库,以帮助目标剖析、设计、生产和验证新的化学探针。为了实现这些目标,我们将实现以下三个具体目标:(1)基于表观遗传功能的表观基因组读取器的靶标分析;(2)使用靶标结构指导策略的探针开发;以及(3)干细胞生物学中基因转录调控功能背景下的探针验证。
英文摘要
DESCRIPTION (provided by applicant): Gene expression of the human genome in response to physiological and environmental stimuli is dictated by chemical modifications of the DNA and the DNA-packing histones, as well as transcription factors. This highly complex biological system that operates with a large number and different combinations of epigenetic modifications has defied our full investigation of its basic mechanisms with existing tools. A prime example is the biology of stem cell in which a balance between self-renewal and differentiation lies at the heart of how its chromatin structure enacts different transcriptional programs to instruct pluripotent cell behavior. Yamanaka's reprogramming of somatic cells to induced pluripotent stem cells using four transcription factors Oct3/4, Sox2, Klf4 and c-Myc (OSKM) highlights the ultimate control of cell fate by gene transcription. However, the questions on how the OSKM factors transform the cell's epigenome and how their own expression are controlled during stem cell self-renewal and differentiation are yet to be answered. The functional effects of epigenetic modifications are realized by the binding of epigenome readers such as the acetyl-lysine binding bromodomain and the methyl-lysine binding chromodomain that are present in transcription and chromatin regulators. Unlike RNA interference or gene knockout that entails the removal of an entire protein along with all its interactions, a small-molecule inhibitor (chemical probe) could remove a single interaction in a multi-domain protein in its endogenous form, thus providing a much finer tool for the temporal perturbation of the complex biological system. In this multidisciplinary research project, we will develop high affinity and selective chemical probes for a selected group of bromodomains and chromodomains that function in stem cell biology, either individually (i.e. single-target probes) or as a group in a biological pathway (i.e. multi-target probes). Our study uses a coherent set of structural/chemical biology and chromatin/stem cell biology methods being developed by our key investigators with multidisciplinary expertise. We will also develop an Epigenome Reader KnowledgeBase to aid target profiling, design, production and validation of new chemical probes. To attain these goals, we will achieve the following three specific aims: (1) Target profiling of epigenome readers based on their epigenetic functions; (2) Probe development using target structure-guided strategy; and (3) Probe validation in a functional context of gene transcriptional regulation in stem cell biology.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1021/jm401334s
发表时间:
2013-11-27
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Zhang G, Plotnikov AN, Rusinova E, Shen T, Morohashi K, Joshua J, Zeng L, Mujtaba S, Ohlmeyer M, Zhou MM]
通讯作者:
Zhou MM
Thermodynamic basis of selectivity in guide-target-mismatched RNA interference.
引导-靶标-错配 RNA 干扰选择性的热力学基础。
DOI:
10.1002/prot.24025
发表时间:
2012-05
期刊:
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
影响因子:
2.9
作者:
[Joseph, Thomas T., Osman, Roman]
通讯作者:
Osman, Roman
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10358485
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10089421
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10582673
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:10025103
-
项目类别:
-
资助金额:$11.87万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Transcriptional Mechanism of BRD4 in Solid Tumor
-
批准号:9883764
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2019
-
负责人:Ming-Ming Zhou
-
依托单位:
Mechanism of BET Proteins in Th17 Cell Differentiation
-
批准号:9241951
-
项目类别:
-
资助金额:$42.38万
-
财政年份:2016
-
负责人:Ming-Ming Zhou
-
依托单位:
Molecular Interactions and Regulation of p53
-
批准号:8288894
-
项目类别:
-
资助金额:$28.01万
-
财政年份:2011
-
负责人:Ming-Ming Zhou
-
依托单位:
Molecular Interactions and Regulation of p53
-
批准号:7896964
-
项目类别:
-
资助金额:$20.86万
-
财政年份:2010
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7943541
-
项目类别:
-
资助金额:$59.73万
-
财政年份:2009
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:8332917
-
项目类别:
-
资助金额:$93.74万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigentic Regulation
-
批准号:8237707
-
项目类别:
-
资助金额:$94.63万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigentic Regulation
-
批准号:8426134
-
项目类别:
-
资助金额:$47.41万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7691399
-
项目类别:
-
资助金额:$91.93万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7930711
-
项目类别:
-
资助金额:$93.74万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Chemical Genomics Paradigm for Epigenetic Regulation
-
批准号:7523730
-
项目类别:
-
资助金额:$93.67万
-
财政年份:2008
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7489881
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7268844
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7142849
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
Structure and Mechanism of Pathogen SET Domain HKMTs
-
批准号:7669158
-
项目类别:
-
资助金额:$25.21万
-
财政年份:2006
-
负责人:Ming-Ming Zhou
-
依托单位:
AUTOMATIC LIQUID HANDLING SYSTEM: CANCER
-
批准号:7166695
-
项目类别:
-
资助金额:$6.98万
-
财政年份:2005
-
负责人:Ming-Ming Zhou
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: